September 10, 2012

CAS databases provide millions of journal article references from more than 10,000 major scientific journals worldwide, patent and patent family references from 63 patent authorities around the world, and other reputable web sources.

The following patent record is from the CAplusSM database.

CAPLUS COPYRIGHT 2012 ACS

Patent Number: US 8232395
Title: Method for producing 2-(2-amino-pyrimidin-4-yl)-1H-indole-5-carboxylic acid derivatives
Inventor(s): Graeser, Joachim; Billen, Guenter; Linkies, Adolf; Metzenthin, Tobias
Patent Assignee(s): Sanofi-Aventis Deutschland G.m.b.H., Germany
Source: PCT Int. Appl., 54pp. CODEN: PIXXD2
Language: German

Abstract:
The invention relates to a method for producing the compds. of formula I, to novel intermediates obtained during the production of the compds. of formula I and to their use as intermediates for producing IkB kinase inhibitors.  Compds. of formula I wherein R1 is H, C1-12 alkyl, C6-14 aryl, C3-8 cycloalkyl, and 4- to 15-membered heterocycle; R2 and R3 are independently H, C1-12 alkyl, (un)substituted C6-14 aryl, C3-8 cycloalkyl and 4- to 15-membered heterocycle; P is H and N-protecting group; and their method for preparing them are claimed.  Example compound II was prepared by alkynylation of Me 4-amino-3-iodobenzoate with trimethylsilylacetylene; the resulting 4-amino-3-(trimethylsilylethynyl)benzoic acid Me ester underwent desilylation to give 4-amino-3-ethynylbenzoic acid Me ester, which underwent cross-coupling with 2-(methylamino)-4-chloropyrimidine to give 4-amino-3-[(2-methylaminopyrimidin-4-yl)ethynyl]benzoic acid Me ester, which underwent cyclization to give compound II.

Please note:  Abstracts for patent records in CAplus are routinely enhanced to better describe the claimed invention. In this example, CAS enhanced the abstract using additional information found in the patent.

 

View the full-text U.S. patent from USPTO.

Recent News


    June 29, 2015 | CAS Assigns the 100 Millionth CAS
    Registry Number to a Substance Designed to
    Treat Acute Myeloid Leukemia
   
    March 17, 2015 | New Content Provides Regulatory
    Professionals with Additional Value

    February 9, 2015 | Major New STN Release Delivers
    Essential Biomedical and Patent Content to IP
    Professionals

                                                                       More News >> 
 
 

Media Contact

 Name: Rhonda Ross
 Phone: 614-447-3624
 Email: cas-pr@cas.org